Global Dry Eye Syndrome Treatment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Dry Eye Syndrome Treatment Market Research Report 2024
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
In this report, we mainly study the drugs and eye drops for dry eye.
According to Mr Accuracy reports’s new survey, global Dry Eye Syndrome Treatment market is projected to reach US$ 7375.6 million in 2034, increasing from US$ 5385 million in 2024, with the CAGR of 4.5% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dry Eye Syndrome Treatment market research.
Global Dry Eye Syndrome key players include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, etc. Global top five manufacturers hold a share over 60%.
North America is the largest market, with a share over 55%, followed by Europe and Asia-Pacific, both have a share over 35 percent.
In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital, followed by Retail Pharmacy.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dry Eye Syndrome Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Novartis
Allergan
Otsuka
Santen Pharmaceutical
Nicox
Auven Therapeutics
Akorn
Bausch & Lomb
Alimera
GlaxoSmithKline
Segment by Type
Liquid Drops
Gel
Liquid Wipes
Eye Ointment
Other
Hospital
Clinic
Home Care
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Dry Eye Syndrome Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
In this report, we mainly study the drugs and eye drops for dry eye.
According to Mr Accuracy reports’s new survey, global Dry Eye Syndrome Treatment market is projected to reach US$ 7375.6 million in 2034, increasing from US$ 5385 million in 2024, with the CAGR of 4.5% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dry Eye Syndrome Treatment market research.
Global Dry Eye Syndrome key players include Allergan, Alcon, Novartis, Santen Pharma, Johnson & Johnson, etc. Global top five manufacturers hold a share over 60%.
North America is the largest market, with a share over 55%, followed by Europe and Asia-Pacific, both have a share over 35 percent.
In terms of product, Anti-inflammatory Drugs is the largest segment, with a share over 50%. And in terms of application, the largest application is Hospital, followed by Retail Pharmacy.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dry Eye Syndrome Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
Novartis
Allergan
Otsuka
Santen Pharmaceutical
Nicox
Auven Therapeutics
Akorn
Bausch & Lomb
Alimera
GlaxoSmithKline
Segment by Type
Liquid Drops
Gel
Liquid Wipes
Eye Ointment
Other
Segment by Application
Hospital
Clinic
Home Care
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Dry Eye Syndrome Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
